Documente Academic
Documente Profesional
Documente Cultură
1- 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease : A
Report of the American College of Cardiology; 2-www.guidelines.co.uk: Consensus Guideline for the Management of Stable Angina in Primary Care.
PULS
Durata diastolei
Munca inimii
Fluxul coronarian
Raportul
oferta/cerere de
oxigen
↓ CAPACITATEA DE
CRIZE ANGINOASE
EFORT
Palatini P. Eur Heart J supplements 1999 (Suppl B):B3-B9
Relatia dintre frecventa cardiaca si ischemie
80 3
70 2
60 1
50
0
0:00 am 12:00 0:00 am Propranolol Diltiazem Placebo
(Timp)
60
50
40
30
20
10
0
45-60 61-70 71-80 81-90 91-100 101-110
Frecventa cardiaca medie (bpm)
1.0 1.0
0.9
Supravietuirea - cumulat
0.9
Supravietuirea - cumulat
0.7 P<0.0001
0.7
0.6 0.6
=<62
=>83 bpm
0.5 0.5
0 5 10 15 20 0 5 10 15 20
Ani Ani
Pacienti cu boala coronariana stabila
Diaz A, et al. Eur Heart J. 2005;26:867-874.
Studiul INVEST (August 2008) a constatat
INVEST
cresterea riscului la hipertensivii coronarieni
60 4.5
Evenimente (mortalitate generala, IM sau AVC non-fatal)
Incidenta efectelor adverse (%)
4.0
50
3 3.7
2 P<0.0001
0.7
0
Includere dupa 4 luni
ATP II
ATP I
ATP I
ATP II
- 10 bpm
-22 bpm
100
Timp de efort
62 suplimentar
60
1-Fox K et al, Eur Heart J 2009, doi:10.1093/eurheartj/ehp358. 2- Nissen SE et al. JAMA. 2004;292:2217-2225. 3- Poole Wilson PA et al. Lancet. 2004;364:849-857. 4- Dargie HJ.
Lancet. 2002;359:1269-1275. 5- Morrow DAet al; for the MERLIN-TIMI 36 Trial Investigators. JAMA. 2007;297:1775–1783.
Creste capacitatea de efort in
insuficienta cardiaca
2.Swedberg K. et al. SHIFT Investigator. Lancet 2010 Sept 11; 376(9744):875-885; 3. Rezumatul caracteristicilor produsului.
Concluzi
e
Frecventa cardiaca > 70 bpm creste riscul de morbi-
mortalitate cardiovasculara